Management Approach for Suspicious Soft Tissue Mass in the Thigh
A suspicious soft tissue mass in the thigh with characteristics worrisome for a neoplastic process should be immediately referred to a specialist sarcoma multidisciplinary team (MDT) for comprehensive evaluation and management. 1
Initial Evaluation
- Any patient with an unexplained lump that is increasing in size should undergo an urgent direct access ultrasound scan within 2 weeks 1
- CT findings of an irregular, multilobulated, heterogeneously enhancing mass with intralesional calcifications strongly suggest a potential sarcoma and require prompt specialist assessment 1
- The presence of mass effect in the anterior compartment of the thigh further increases concern for malignancy and requires expedited management 1
Diagnostic Pathway
Imaging Studies
- MRI of the affected region should be performed as it provides the most accurate information for diagnosis and surgical/radiotherapy planning for extremity soft tissue tumors 1
- CT chest should be performed to exclude pulmonary metastases, as soft tissue sarcomas have a predominant pattern of metastases to the lungs 1
- Consider including abdomen and pelvis in the CT staging, especially for high-grade sarcomas of the lower extremities 1
- Regional lymph node assessment by ultrasound or cross-sectional imaging should be considered, particularly if synovial sarcoma, clear cell sarcoma, angiosarcoma, or epithelioid sarcoma is suspected 1
- PET-CT may be considered before performing radical surgery, though it is not yet proven as a routine investigation in sarcoma 1
Biopsy
- Percutaneous core needle biopsy is the standard approach to establish histopathological diagnosis 1
- Multiple cores should be taken to maximize diagnostic yield, typically performed under image guidance by a radiologist 1
- The biopsy should be planned so that the biopsy tract can be safely removed during definitive surgery 1
- Fine needle aspiration is not recommended as a primary diagnostic modality 1
Specialist Referral
- Any patient with ultrasound findings suggestive of soft tissue sarcoma should be referred via a suspected cancer pathway for an appointment within 2 weeks 1
- All patients with suspected soft tissue sarcoma should be managed by a specialist Sarcoma MDT as specified in the NICE guidance 1
- Treatment at specialized cancer centers is associated with improved survival, particularly for adolescents and young adults with soft tissue sarcomas 2
Histopathological Assessment
- Histological diagnosis should be made according to the 2020 WHO Classification of Soft tissue and bone to determine the grade and stage of the tumor 1
- A soft tissue specialist pathology review of diagnostic biopsies performed outside sarcoma centers is recommended due to high discrepancy rates (8-11% for major discordance, 16-35% for minor discordance) 1
- Tumor grade should be provided in all cases where possible based on a recognized system such as the FNCLCC grading system 1
Common Pitfalls to Avoid
- Performing "whoops surgery" (inadequate excision without proper preoperative planning) should be avoided as it often necessitates more extensive subsequent surgery 3, 4
- Relying solely on ultrasound assessment without MRI in cases of diagnostic uncertainty can lead to misdiagnosis due to the user-dependent nature of ultrasound 1
- Underestimating the extent of the tumor can result in inadequate surgical margins and increased risk of local recurrence 3, 4
- Delaying referral to specialist centers can negatively impact survival outcomes, particularly in adolescents and young adults 2
Special Considerations
- For subcutaneous soft tissue masses, careful assessment of growth speed, firmness, and mobility can provide valuable diagnostic information 3
- Masses that are deep to the fascia, are 5 cm or larger, grow rapidly, or present suddenly without explanation should prompt urgent further workup 4
- Post-radiotherapy MRI changes can sometimes mimic tumor recurrence, requiring careful interpretation in conjunction with clinical findings 5